(Q51043480)

27 March 2018

title

Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. (English)

1 reference

27 March 2018

1 reference

Malgorzata Banys

1

1 reference

27 March 2018

Ines Gruber

2

1 reference

27 March 2018

Natalia Krawczyk

3

1 reference

27 March 2018

Sven Becker

4

1 reference

27 March 2018

Ralph Kurth

5

1 reference

27 March 2018

Diethelm Wallwiener

6

1 reference

27 March 2018

Jolanta Jakubowska

7

1 reference

27 March 2018

Jürgen Hoffmann

8

1 reference

27 March 2018

Ralf Rothmund

9

1 reference

27 March 2018

Annette Staebler

10

1 reference

27 March 2018

Tanja Fehm

11

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 April 2011

1 reference

27 March 2018

Breast Cancer Research and Treatment

published in

1 reference

27 March 2018

volume

131

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

801-808

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1007/s10549-011-1478-2

exact match

0 references

cites work

Recent advances and current controversies in the management of DCIS of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Detection of ductal carcinoma in situ in women undergoing screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Incidence of and treatment for ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

In situ analyses of genome instability in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

On the growth rates of human malignant tumors: implications for medical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

The process of metastasisation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Seeding and propagation of untransformed mouse mammary cells in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Sentinel node biopsy in ductal carcinoma in situ patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

Ductal carcinoma in situ: value of sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1478-2

10.1007/S10549-011-1478-2

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018